StemCell Institute (TSE:7096) Current Deferred Revenue : 円0 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

StemCell Institute's current deferred revenue for the quarter that ended in Sep. 2024 was 円0 Mil.

StemCell Institute Current Deferred Revenue Historical Data

The historical data trend for StemCell Institute's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Current Deferred Revenue Chart

StemCell Institute Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Current Deferred Revenue

Get a 7-Day Free Trial

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Current Deferred Revenue	Get a 7-Day Free Trial													-	-	-	-	-

StemCell Institute Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines